EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 -0.8505
March 31, 2026 -0.9684
December 31, 2025 -1.026
September 30, 2025 -0.994
June 30, 2025 -1.224
March 31, 2025 -1.124
December 31, 2024 -1.206
September 30, 2024 -0.0662
June 30, 2024 -0.0845
March 31, 2024 -0.1021
December 31, 2023 -0.1072
September 30, 2023 -0.1071
June 30, 2023 -0.1416
March 31, 2023 -0.1459
December 31, 2022 -0.1251
September 30, 2022 -0.138
June 30, 2022 -0.1422
March 31, 2022 -0.142
December 31, 2021 -0.1505
September 30, 2021 -0.1342
June 30, 2021 -0.1044
March 31, 2021 -0.1201
December 31, 2020 -0.1057
September 30, 2020 -0.092
June 30, 2020 -0.116
Date Value
March 31, 2020 -0.142
December 31, 2019 -0.0865
September 30, 2019 -0.1048
June 30, 2019 -0.1069
March 31, 2019 -0.1161
December 31, 2018 -0.12
September 30, 2018 -0.14
June 30, 2018 -0.15
March 31, 2018 -0.17
December 31, 2017 -3.00
September 30, 2017 -3.00
June 30, 2017 -2.60
March 31, 2017 -0.13
December 31, 2016 -0.12
September 30, 2016 -0.15
June 30, 2016 -0.13
March 31, 2016 -0.13
December 31, 2015 -0.14
September 30, 2015 -0.16
June 30, 2015 -0.10
March 31, 2015 -0.12
December 31, 2014 -0.06
September 30, 2014 -0.44
June 30, 2014 0.06
March 31, 2014 -0.18

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 4.267
Neogen Corp. -0.0519
QuidelOrtho Corp. -1.360
Aspira Women's Health, Inc. -0.0547
Lucid Diagnostics, Inc. -0.0804